Teizeild

Teizeild is a diabetes medicine used to treat adults and children from 8 years of age with stage 2 type 1 diabetes. It is used to delay the disease progressing to stage 3. In type 1 diabetes, the immune system (the body’s natural defences) attacks the insulin-producing cells in the pancreas (called beta cells). Insulin is a hormone that regulates the amount of blood glucose (sugar) in the blood. At stage 2 of the disease, blood sugar levels start to increase and become abnormal because the pancreas is no longer able to produce enough insulin. Symptoms normally appear at stage 3, when the pancreas produces even less insulin and treatment with insulin is needed to manage blood glucose levels. Teizeild contains the active substance teplizumab.